When it comes to researching shares, many investors take note of what city analysts have to say. The trading recommendations of these professionals are used by everyone from institutional fund managers to individual private investors....
CRW — Craneware Share Price
- £574.01m
- £637.15m
- $75.58m
- 71
- 15
- 40
- 33
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 19.79 | ||
PEG Ratio (f) | 2.33 | ||
EPS Growth (f) | 9.3% | ||
Dividend Yield (f) | 2.07% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.08 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 91.13 | ||
Price to Sales | 5.9 | ||
EV to EBITDA | 28.31 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.23% | ||
Return on Equity | 4.51% | ||
Operating Margin | 9.28% |
Financial Summary
Year End 30th Jun | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 57.8 | 67.07 | 71.4 | 71.49 | 75.58 | 175.47 | 193.1 | 8.68% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +21.46 | +21.63 | -2.11 | +5.8 | +17.41 | +24.25 | +9.3 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Latest News & Insights for CRW
When it comes to looking for stock market investment ideas, broker recommendations can be a useful place to start. These city experts tend to know the companies they cover inside-out, so their views can be valuable. They're even more v...
Shares in Craneware (LON:CRW) are currently trading at 2,400p but a key question for investors is whether it's well-placed to make progress from here. Part of the answer could come down to whether it is well placed to ride out economic...
Some shares have withstood the economic shockwaves caused by Covid-19 better than others - but is Craneware (LON:CRW) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their strength...
The Craneware (LON:CRW) share price is currently trading at 2,310p. But given the uncertain economic outlook, the question now is what the future holds for it. To try and predict where the Craneware price will head next, it's worth kno...
Profile Summary
Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The Company's Value Cycle Solutions has five product families, which include Patient Engagement, Charge Capture & Pricing, Claims Analytics, Cost and Margin Analytics, and Revenue Recovery & Retention. Its Patient Engagement solutions include InSight Medical Necessity, which provides access to medical necessity and prior authorization policies for Medicare, Medicare supplements and commercial payors impacting customers facility. Its Charge Capture & Pricing solution include Chargemaster Toolkit, Trisus Pricing Transparency, Trisus Pharmacy Financial Management, Trisus Pricing Analyzer, Online Reference Toolkit, and others. Its Claims Analytics solution include Trisus Claims Informatics. Its Revenue Recovery & Retention solution include InSight Denials, InSight Audit and Appeals Services.
Directors
- William Whitehorn NEC (61)
- Keith Neilson CEO (52)
- Craig Preston CFO (50)
- Colleen Blye NID (61)
- Alistair Erskine NID (51)
- David Kemp NID (51)
- Russ Rudish NID (69)
- Last Annual
- June 30th, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- May 19th, 1999
- Public Since
- September 13th, 2007
- No. of Employees
- 370
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
London Stock Exchange
- Shares in Issue
- 35,542,169

- Address
- 1 Tanfield, EDINBURGH, EH3 5DA
- Web
- https://public.craneware.com/
- Phone
- +44 1315503100
- Contact
- Caroline Forde
- Auditors
- PricewaterhouseCoopers LLP
Latest News for CRW
Upcoming Events for CRW
Full Year 2022 Craneware PLC Earnings Release
Craneware PLC Annual Shareholders Meeting
Similar to CRW
1Spatial
London Stock Exchange
4Global
London Stock Exchange
Access Intelligence
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
FAQ
As of Today at 19:05 UTC, shares in Craneware are trading at 1,615.00p. This share price information is delayed by 15 minutes.
Shares in Craneware last closed at 1,615.00p and the price had moved by -24.88% over the past 365 days. In terms of relative price strength the Craneware share price has underperformed the FTSE All Share Index by -22.48% over the past year.
The overall consensus recommendation for Craneware is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Craneware dividend yield is 1.96% based on the trailing twelve month period.
Last year, Craneware paid a total dividend of $0.38, and it currently has a trailing dividend yield of 1.96%. We do not have any data on when Craneware is to next pay dividends.
We do not have data on when Craneware is to next pay dividends. The historic dividend yield on Craneware shares is currently 1.96%.
To buy shares in Craneware you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1,615.00p, shares in Craneware had a market capitalisation of £574.01m.
Here are the trading details for Craneware:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: CRW
Based on an overall assessment of its quality, value and momentum Craneware is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Craneware is 2,787.33p. That is 72.59% above the last closing price of 1,615.00p.
Analysts covering Craneware currently have a consensus Earnings Per Share (EPS) forecast of $0.90 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Craneware. Over the past six months, its share price has underperformed the FTSE All Share Index by -27.72%.
As of the last closing price of 1,615.00p, shares in Craneware were trading -19.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Craneware PE ratio based on its reported earnings over the past 12 months is 19.79. The shares last closed at 1,615.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Craneware's management team is headed by:
- William Whitehorn - NEC
- Keith Neilson - CEO
- Craig Preston - CFO
- Colleen Blye - NID
- Alistair Erskine - NID
- David Kemp - NID
- Russ Rudish - NID